Technical Analysis for NKGN - NKGen Biotech, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | -8.06% | |
Wide Bands | Range Expansion | -8.06% | |
Oversold Stochastic | Weakness | -8.06% | |
Narrow Range Bar | Range Contraction | -9.52% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 16 hours ago |
Down 1% | about 16 hours ago |
Possible Inside Day | about 16 hours ago |
Up 3% | about 19 hours ago |
Up 2% | about 19 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials. The company was founded in 2017 and is based in Santa Ana, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immune System Stem Cell Cell Therapy Cell Biology Natural Killer Cell Lymphocytes
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immune System Stem Cell Cell Therapy Cell Biology Natural Killer Cell Lymphocytes
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.88 |
52 Week Low | 0.7802 |
Average Volume | 4,468,803 |
200-Day Moving Average | 4.00 |
50-Day Moving Average | 1.61 |
20-Day Moving Average | 1.40 |
10-Day Moving Average | 1.28 |
Average True Range | 0.21 |
RSI (14) | 41.18 |
ADX | 14.75 |
+DI | 18.34 |
-DI | 21.09 |
Chandelier Exit (Long, 3 ATRs) | 1.48 |
Chandelier Exit (Short, 3 ATRs) | 1.45 |
Upper Bollinger Bands | 1.92 |
Lower Bollinger Band | 0.88 |
Percent B (%b) | 0.25 |
BandWidth | 74.72 |
MACD Line | -0.09 |
MACD Signal Line | -0.07 |
MACD Histogram | -0.0257 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.24 | ||||
Resistance 3 (R3) | 1.25 | 1.22 | 1.23 | ||
Resistance 2 (R2) | 1.22 | 1.19 | 1.22 | 1.22 | |
Resistance 1 (R1) | 1.18 | 1.18 | 1.17 | 1.17 | 1.22 |
Pivot Point | 1.15 | 1.15 | 1.15 | 1.15 | 1.15 |
Support 1 (S1) | 1.11 | 1.12 | 1.11 | 1.11 | 1.06 |
Support 2 (S2) | 1.08 | 1.11 | 1.08 | 1.06 | |
Support 3 (S3) | 1.04 | 1.08 | 1.05 | ||
Support 4 (S4) | 1.04 |